Comparison between Matched Related and Alternative Donors of Allogeneic Hematopoietic Stem Cells Transplanted into Adult Patients with Acquired Aplastic Anemia: Multivariate and Propensity Score-Matched Analysisopen access
- Authors
- Kim, Hawk; Kim, Byung Soo; Kim, Dong Hwan; Hyun, Myung Soo; Kim, Sung Hyun; Bae, Sung Hwa; Choi, Jung Hye; Sohn, Sang Kyun; Shin, Ho Jin; Won, Jong Ho; Yoon, Sung-Soo; Jo, Deog-Yoen; Joo, Young Don; Park, Jae-Hoo; Lee, Kyoo-Hyung
- Issue Date
- Sep-2011
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- Matched related donor; Alternative donor; Adult; Aplastic anemia; Hematopoietic stem cell transplantation
- Citation
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, v.17, no.9, pp.1289 - 1298
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Volume
- 17
- Number
- 9
- Start Page
- 1289
- End Page
- 1298
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/167710
- DOI
- 10.1016/j.bbmt.2010.12.715
- ISSN
- 1083-8791
- Abstract
- We retrospectively compared the outcomes of 225 patients with adult acquired aplastic anemia (AA) who underwent allogeneic hematopoietic stem cell transplantation (alloHSCT) from matched related donors (MRDs), and those treated by alloHSCT from alternative donors (ADs). Univariate and multivariate analyses of factors associated with survival were performed. Multivariate analysis showed that age at alloHSCT of <= 31 years, MRD, successful engraftment, absence of acute graft-versus-host disease (aGVHD), and platelet engraftment at <= 21 days, were independent predictors of longer survival. In addition, time to aGVHD and cumulative nonrelapse mortality (NRM) were better in MRD than in AD recipients. Using propensity score matching (PSM), we performed a case-control study comparing 25 patients in each group who underwent alloHSCT from MRDs and ADs. Pretransplantation clinical factors were well balanced in either group. Median survival time was similar, and no statistically significant difference in transplantation outcomes was apparent when MRD and AD recipients were compared. In conclusion, our results suggest that alloHSCT from an AD should be considered earlier in adult patients with AA who do not have an MRD. Biol Blood Marrow Transplant 17: 1289-1298 (2011)
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/167710)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.